The Sales Podcast With Wes Schaeffer, The Sales Whisperer®
How Not To F-Up AI & CRM by Michael Hudlow
12 Jun 2024
In this conversation, Wes and Michael Hudlow discuss the use of AI in CRM systems. https://blog.thesaleswhisperer.com/p/michael-hudlow-2 They talk about Michael's experience writing a book on AI and how he used AI tools in the process. They also discuss the importance of human interaction in business and the potential risks and benefits of AI. Michael explains how AI can be used in CRM systems for the automation of emails, live account insights, lead conversion, lead scoring, and customer retention. He also emphasizes the need for companies to have a policy on the proper use of AI. The conversation explores the role of AI in business and the importance of asking the right questions when implementing AI tools. It emphasizes the value of human intelligence, ethics, and proper problem-solving processes in conjunction with AI. The discussion also touches on the misuse of AI in spamming and the need for responsible AI practices. The guest shares insights from his books on AI and offers practical advice for companies and individuals navigating the AI landscape. Takeaways AI can be used in CRM systems for automation of emails, live account insights, lead conversion, lead scoring, and customer retention. Companies should have a policy on the proper use of AI to avoid potential risks and ensure responsible use. Human interaction and personalization are still important in business, and AI should be used to enhance these aspects rather than replace them. AI tools can help clean and standardize data in CRM systems, improving data quality and accuracy. AI is a powerful tool, but it should be used in conjunction with human intelligence, ethics, and proper problem-solving processes. The value of AI lies in asking the right questions and understanding the actual problems that need to be solved. Misuse of AI, such as spamming, can have negative consequences and should be avoided. Companies and individuals should approach AI implementation with caution and ensure proper policies and protections are in place. Human oversight is crucial in reviewing AI-generated outputs and ensuring responsible practices. Market like you mean it. Now go sell something. Name your price for the Make Every Sale Program here: https://saleswhisperer.gumroad.com/l/OiXZk SUBSCRIBE to sell more, faster, at higher margins, with less stress, and more fun! https://www.youtube.com/@TheSalesWhispererWes ----- Connect with me: Twitter -- https://twitter.com/saleswhisperer TikTok -- https://www.tiktok.com/@thesaleswhisperer Instagram -- http://instagram.com/saleswhisperer LinkedIn -- http://www.linkedin.com/in/thesaleswhisperer/ Facebook -- https://www.facebook.com/wes.sandiegocrm Facebook Page -- https://www.facebook.com/thesaleswhisperer Vimeo -- https://vimeo.com/thesaleswhisperer Podcast -- https://feeds.libsyn.com/44487/rss YouTube — https://www.youtube.com/@TheSalesWhispererWes Sales Book -- https://www.thesaleswhisperer.com/c/way-book BUSINESS GROWTH TOOLS https://12WeeksToPeak.com https://CopyByWes.com https://CRMQuiz.com https://TheBestSalesSecrets.com https://MakeEverySale.com https://www.TheSalesWhisperer.com/ https://www.thesaleswhisperer.com/c/ipa
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare